Hiển thị các bài đăng có nhãn suppression of medical research. Hiển thị tất cả bài đăng
Hiển thị các bài đăng có nhãn suppression of medical research. Hiển thị tất cả bài đăng
Thứ Tư, 2 tháng 7, 2014

What Does the Blumsohn - Procter and Gamble -Sheffield University Affair Say About the Fitness of the Latest VA Secretary Candidate?

›
Introduction - New Leadership for the US Department of Veterans Affairs After reports of problems with access, manipulation of data about wa...
Thứ Năm, 26 tháng 12, 2013

No Needle, but the Damage was Done - A New Example of Suppression of Research about Adverse Effects of Prescription Narcotic Analgesics

›
This story feels personal, since as a physician who trained starting in the 1970s, figuring out how to manage patients who desperately wante...
Thứ Sáu, 29 tháng 11, 2013

There They Go Again, Again... - Johnson and Johnson Loses Two Civil Cases, Makes $2.5 Billion Settlement Based on Claims it Withheld Safety Data on its Products

›
There has been some talk by US government officials that any day now they will actually get tough on corporate executives whose organization...
Thứ Năm, 12 tháng 9, 2013

Why Trust Drug Company Executives After One Admits Commercially Sponsored Clinical Research Is All About "Competitive Advantage?"

›
Mickey, the semi-anonymous blogger on 1BoringOldMan, wrote a righteously angry post in support of transparent clinical research.  As we hav...
Thứ Hai, 22 tháng 7, 2013

Pharmaceutical Industry "'Mobilised' an Army of Patient Groups to Lobby Against" Improving Clinical Research Integrity

›
I had guessed that this sort of thing was going on all the time, but being kept very well hidden.  Now we have some more evidence. An artic...
Thứ Tư, 19 tháng 6, 2013

A Call to Restore the Integrity of Clinical Research - but Will Anyone Heed it?

›
Concerns about suppression and manipulation of clinical research to serve vested interests have finally gotten a little more mainstream. B...
Thứ Bảy, 2 tháng 2, 2013

A Condemnation of Suppression of Medical Research... by Ben Goldacre in the New York Times

›
Amazingly, this topic now seems to be in the mainstream. The Goldacre Version in the New York Times in 2013 In his op-ed , Ben Goldacre intr...
Thứ Năm, 3 tháng 1, 2013

Oh, the Prices we Pay ... for Questionable Drug Marketing to Enrich Corporate Insiders - the Case of Questcor's H P Acthar Revisited

›
In 2007, we first discussed the case of the amazing pricing of H P Acthar, a very old drug of questionable usefulness, as an example of the...